Summary & Overview
HCPCS M1024: Adolescent Depression Nonremission at Six Months
HCPCS Level II code M1024 identifies adolescent patients (ages 12–17) with major depression or dysthymia who have not achieved remission at six months, as demonstrated by a six-month (+/-60 days) PHQ-9 or PHQ-9M score of 5 or higher, or when the six-month assessment was not completed. Nationally, this code signals persistent depressive symptoms in adolescents and is used to track ongoing severity and need for continued or adjusted treatment. It is relevant for quality measurement, care coordination, and longitudinal outcome monitoring in pediatric behavioral health programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the code, typical service settings, and the primary purposes for use: documenting nonremission, supporting follow-up care pathways, and enabling performance measurement. The publication outlines available benchmarks and reporting considerations where data is present and notes when input fields are unavailable.
The report provides operational details for clinicians and billing teams, clarifies where this code fits in adolescent depression care workflows, and summarizes the documentation elements tied to a six-month PHQ-9 or PHQ-9M assessment. Data not available in the input is identified explicitly in relevant sections.
Billing Code Overview
HCPCS Level II code M1024 identifies adolescent patients aged 12 to 17 years with major depression or dysthymia who have not reached remission at six months. The code applies when a six-month (+/- 60 days) PHQ-9 or PHQ-9M assessment shows a score of greater than or equal to 5, or when a six-month PHQ-9 or PHQ-9M score was not assessed. This reflects ongoing depressive symptoms or a lack of documented remission after an acute treatment period.
Service Type: Depression severity assessment and care monitoring for adolescents
Typical Site of Service: Outpatient behavioral health clinics, pediatric or adolescent psychiatry clinics, primary care clinics providing behavioral health follow-up, and community mental health centers
Clinical & Coding Specifications
Clinical Context
An adolescent aged 12–17 with a documented diagnosis of major depressive disorder or persistent depressive disorder (dysthymia) enters a six-month follow-up evaluation after initiation of psychotherapy, pharmacotherapy, or combined treatment. The clinic schedules a standardized symptom assessment using the Patient Health Questionnaire for Adolescents (PHQ-9 or PHQ-9m) within the six-month window (±60 days). If the standardized score is not <5 (remission threshold) or if no PHQ-9/PHQ-9m was completed, the patient meets the criteria described by billing code M1024 for documentation of non-remission at six months.
A typical workflow:
-
At treatment initiation the clinician documents baseline diagnosis, treatment plan, and schedules follow-up assessments.
-
At approximately six months, front-desk or nursing staff administers the
PHQ-9orPHQ-9min-person or via secure patient portal; results are entered into the electronic health record. -
The treating clinician reviews the
PHQ-9/PHQ-9mscore, documents that remission (score <5) was not achieved, and records clinical decision-making (e.g., treatment adjustment, referral, safety plan) in the progress note.